Fig. 1.

Prisma diagram of the study selection. Study identification, screening, and final inclusion in the scoping review are shown. Search strategies identified 1,164 citations total. Ninety-seven duplicates were removed, leaving a set of 1,067 citations for title/abstract screening. Of these, 137 articles were deemed relevant and 930 were excluded after initial screening by the team. The team then excluded 63 studies because 48 did not include community or clinical champions within translational research across the cancer care continuum (i.e., prevention, screening, treatment, survivorship/rehabilitation), 7 were not about cancer research, 6 were a type of publication not included in the review, and 1 was conducted in a setting not included in the review. A single duplicate study was also removed at this stage. A total of 74 articles were deemed eligible and included in the review